DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
Trusted Resources: News & Events
Latest announcements and gatherings
Sickle Cell Disease Research Shows Progress in Preventing Related Complications and Death
Studies aim to limit pain crises, prevent strokes in kids, and save the lives of pregnant women with SCD.
Sickle cell disease (SCD) is an inherited chronic disorder characterized by rigid, sickle-shaped red blood cells that get stuck in veins and block blood flow, which can cause severe pain, stroke, organ failure, and complications leading to death. Each year, approximately 300,000 people around the world are born with SCD, and most of them lack access to comprehensive care or effective treatment options. In fact, the only established long-term therapy for SCD, a pill called hydroxyurea approved more than a decade ago to treat complications stemming from the disease, is widely underused in resource-poor countries.
There is an enormous need to improve the quality of life for people with SCD and decrease global mortality rates. Three studies presented today during the 58th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego report on encouraging advances for SCD treatment that carry global public health implications.


Related Content
-
education & researchNeurocognitive and Psychological Effects of Persistent Pain in Pediatric Sickle Cell DiseaseBackground: Pain is a major complicatio...
-
education & researchDevelopment of a multi-center cohort to evaluate long-term outcomes and late effects following hematopoietic cell tr...Hematopoietic cell transplantation (HCT)...
-
news & eventsNew Pre-transplant Treatment Regimen Improves Survival of Kids with Sickle Cell Disease, Trial ShowsA new pre-transplant conditioning regime...
-
news & eventsKids with sickle cell disease aren’t receiving key vaccines, Michigan study findsA significant proportion of children w...
-
people & placesSam Rodgers-Melnick, MT-BCSamuel Rodgers-Melnick, MT-BC is a music...
-
news & eventsStep toward gene therapy for sickle cell diseaseA team of researchers at the Stanford Un...
-
videos & visualsJazz’ Journey With Sickle Cellhttps://www.youtube.com/watch?v=OMC5wOyD...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by

This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.